Across TCGA pan-cancer cohorts, RNA5SP153 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNA5SP153 data layer.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNA5SP153 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP153 expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.
BLCA and OV are the cancer types where RNA5SP153 RNA most reproducibly stratifies survival.